These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3105236)

  • 41. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.
    Cohen-Cymberknoh M; Gilead N; Gartner S; Rovira S; Blau H; Mussaffi H; Rivlin J; Gur M; Shteinberg M; Bentur L; Livnat G; Aviram M; Picard E; Tenenbaum A; Armoni S; Breuer O; Shoseyov D; Kerem E
    J Cyst Fibros; 2016 Nov; 15(6):776-782. PubMed ID: 27143583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.
    Van Daele SG; Franckx H; Verhelst R; Schelstraete P; Haerynck F; Van Simaey L; Claeys G; Vaneechoutte M; de Baets F
    Eur Respir J; 2005 Mar; 25(3):474-81. PubMed ID: 15738291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients.
    Kerem E; Corey M; Stein R; Gold R; Levison H
    Pediatr Infect Dis J; 1990 Jul; 9(7):494-8. PubMed ID: 2115157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Das BK; Dwivedi SN
    BMC Microbiol; 2005 Jul; 5():43. PubMed ID: 16033658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.
    Johansen HK; Høiby N
    Thorax; 1992 Feb; 47(2):109-11. PubMed ID: 1549817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre.
    Proesmans M; Balinska-Miskiewicz W; Dupont L; Bossuyt X; Verhaegen J; Høiby N; de Boeck K
    Eur Respir J; 2006 May; 27(5):937-43. PubMed ID: 16707392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?
    Sommer LM; Marvig RL; Luján A; Koza A; Pressler T; Molin S; Johansen HK
    BMC Genomics; 2016 Aug; 17():589. PubMed ID: 27506816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.
    van Mansfeld R; de Been M; Paganelli F; Yang L; Bonten M; Willems R
    PLoS One; 2016; 11(6):e0158106. PubMed ID: 27337151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
    Bergan T; Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):553-60. PubMed ID: 812335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.
    Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ;
    Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families.
    Laraya-Cuasay LR; Cundy KR; Huang NN
    J Pediatr; 1976 Jul; 89(1):23-6. PubMed ID: 819641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis.
    Al Shidhani K; O’Reilly R; Javadpour S; O’Sullivan N; McNally P; Cox DW
    Ir Med J; 2019 Jun; 112(6):946. PubMed ID: 31535835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.